AFIB — Acutus Medical Income Statement
0.000.00%
Last trade - 00:00- $1.86m
- $21.62m
- $7.16m
Annual income statement for Acutus Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.84 | 8.46 | 17.3 | 3.03 | 7.16 |
| Cost of Revenue | |||||
| Gross Profit | -6.41 | -7.42 | -15.7 | -1.91 | -3.14 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 76.9 | 99.8 | 129 | -30.1 | 18.9 |
| Operating Profit | -74 | -91.3 | -112 | 33.1 | -11.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -97 | -102 | -118 | 28.8 | -11.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -97 | -102 | -118 | 28.8 | -11.9 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -97 | -102 | -118 | -39.6 | -81.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -97 | -102 | -118 | -39.6 | -81.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.85 | -8.94 | -4.11 | -0.345 | -0.613 |
| Dividends per Share |